397 related articles for article (PubMed ID: 18619528)
1. State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers.
Fattal E; Bochot A
Int J Pharm; 2008 Dec; 364(2):237-48. PubMed ID: 18619528
[TBL] [Abstract][Full Text] [Related]
2. Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA.
de Martimprey H; Vauthier C; Malvy C; Couvreur P
Eur J Pharm Biopharm; 2009 Mar; 71(3):490-504. PubMed ID: 18977435
[TBL] [Abstract][Full Text] [Related]
3. Oral delivery of siRNA and antisense oligonucleotides.
Akhtar S
J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907
[TBL] [Abstract][Full Text] [Related]
4. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA.
Fattal E; Bochot A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1203-23. PubMed ID: 17097190
[TBL] [Abstract][Full Text] [Related]
5. Innovative nanotechnologies for the delivery of oligonucleotides and siRNA.
Toub N; Malvy C; Fattal E; Couvreur P
Biomed Pharmacother; 2006 Nov; 60(9):607-20. PubMed ID: 16952435
[TBL] [Abstract][Full Text] [Related]
6. Central administration of small interfering RNAs in rats: a comparison with antisense oligonucleotides.
Senn C; Hangartner C; Moes S; Guerini D; Hofbauer KG
Eur J Pharmacol; 2005 Oct; 522(1-3):30-7. PubMed ID: 16213482
[TBL] [Abstract][Full Text] [Related]
7. Smart polymeric micelles as nanocarriers for oligonucleotides and siRNA delivery.
Kataoka K; Itaka K; Nishiyama N; Yamasaki Y; Oishi M; Nagasaki Y
Nucleic Acids Symp Ser (Oxf); 2005; (49):17-8. PubMed ID: 17150611
[TBL] [Abstract][Full Text] [Related]
8. Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA.
Juliano RL
Curr Opin Mol Ther; 2005 Apr; 7(2):132-6. PubMed ID: 15844620
[TBL] [Abstract][Full Text] [Related]
9. siRNA delivery systems for cancer treatment.
Oh YK; Park TG
Adv Drug Deliv Rev; 2009 Aug; 61(10):850-62. PubMed ID: 19422869
[TBL] [Abstract][Full Text] [Related]
10. Click conjugated polymeric immuno-nanoparticles for targeted siRNA and antisense oligonucleotide delivery.
Chan DP; Deleavey GF; Owen SC; Damha MJ; Shoichet MS
Biomaterials; 2013 Nov; 34(33):8408-15. PubMed ID: 23932248
[TBL] [Abstract][Full Text] [Related]
11. Efficient delivery of intact phosphodiester oligonucleotides by poly-beta-amino esters.
Remaut K; Symens N; Lucas B; Demeester J; De Smedt SC
J Control Release; 2010 May; 144(1):65-74. PubMed ID: 20114066
[TBL] [Abstract][Full Text] [Related]
12. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
[TBL] [Abstract][Full Text] [Related]
13. Antisense applications for biological control.
Pan WH; Clawson GA
J Cell Biochem; 2006 May; 98(1):14-35. PubMed ID: 16440307
[TBL] [Abstract][Full Text] [Related]
14. Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect.
Weyermann J; Lochmann D; Georgens C; Zimmer A
Eur J Pharm Biopharm; 2005 Apr; 59(3):431-8. PubMed ID: 15760723
[TBL] [Abstract][Full Text] [Related]
15. Can we better understand the intracellular behavior of DNA nanoparticles by fluorescence correlation spectroscopy?
Remaut K; Lucas B; Raemdonck K; Braeckmans K; Demeester J; De Smedt SC
J Control Release; 2007 Aug; 121(1-2):49-63. PubMed ID: 17509716
[TBL] [Abstract][Full Text] [Related]
16. The use of cell-penetrating peptides as a tool for gene regulation.
Järver P; Langel U
Drug Discov Today; 2004 May; 9(9):395-402. PubMed ID: 15081956
[TBL] [Abstract][Full Text] [Related]
17. Smart siRNA delivery systems based on polymeric nanoassemblies and nanoparticles.
Tamura A; Nagasaki Y
Nanomedicine (Lond); 2010 Sep; 5(7):1089-102. PubMed ID: 20874023
[TBL] [Abstract][Full Text] [Related]
18. Cellular delivery of siRNA and antisense oligonucleotides via receptor-mediated endocytosis.
Ming X
Expert Opin Drug Deliv; 2011 Apr; 8(4):435-49. PubMed ID: 21381985
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
[TBL] [Abstract][Full Text] [Related]
20. Cationic nanosystems for the delivery of small interfering ribonucleic acid therapeutics: a focus on toxicogenomics.
Akhtar S
Expert Opin Drug Metab Toxicol; 2010 Nov; 6(11):1347-62. PubMed ID: 20929276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
